iKang Healthcare Group (NASDAQ: KANG) is one of 45 public companies in the “Healthcare Facilities & Services” industry, but how does it weigh in compared to its competitors? We will compare iKang Healthcare Group to similar companies based on the strength of its institutional ownership, profitability, earnings, risk, analyst recommendations, valuation and dividends.
This is a breakdown of current ratings for iKang Healthcare Group and its competitors, as reported by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|iKang Healthcare Group||0||0||0||0||N/A|
|iKang Healthcare Group Competitors||257||1520||2031||39||2.48|
Risk and Volatility
iKang Healthcare Group has a beta of 0.26, suggesting that its share price is 74% less volatile than the S&P 500. Comparatively, iKang Healthcare Group’s competitors have a beta of 0.67, suggesting that their average share price is 33% less volatile than the S&P 500.
Insider and Institutional Ownership
33.2% of iKang Healthcare Group shares are held by institutional investors. Comparatively, 69.4% of shares of all “Healthcare Facilities & Services” companies are held by institutional investors. 30.2% of iKang Healthcare Group shares are held by company insiders. Comparatively, 15.2% of shares of all “Healthcare Facilities & Services” companies are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
This table compares iKang Healthcare Group and its competitors’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|iKang Healthcare Group||0.79%||1.30%||0.60%|
|iKang Healthcare Group Competitors||13.21%||0.86%||1.95%|
Valuation and Earnings
This table compares iKang Healthcare Group and its competitors revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Net Income||Price/Earnings Ratio|
|iKang Healthcare Group||$435.71 million||-$11.25 million||448.00|
|iKang Healthcare Group Competitors||$6.36 billion||$164.63 million||329.16|
iKang Healthcare Group’s competitors have higher revenue and earnings than iKang Healthcare Group. iKang Healthcare Group is trading at a higher price-to-earnings ratio than its competitors, indicating that it is currently more expensive than other companies in its industry.
iKang Healthcare Group competitors beat iKang Healthcare Group on 7 of the 10 factors compared.
iKang Healthcare Group Company Profile
iKang Healthcare Group, Inc. provides preventive healthcare solutions, including a range of medical examinations services and value-added services, including disease screening, dental services and other services in China. The Company’s segments include medical examinations and other medical services, and dental services. The Company, through its integrated service platform, offers healthcare management solutions, including medical examinations, which cover basic examination items, such as internal, gynecology, ophthalmology, dental and X-ray, and value-added services at selected medical centers, including disease screening focusing on cancer screening, cardiovascular disease screening, certain chronic disease screening and functional medicine testing; dental care, including oral health, pediatric dentistry and cosmetic dentistry; outpatient services, such as acupuncture, obstetrics, gynecology and minor surgery, and on-site healthcare management or clinics at certain locations.
Receive News & Ratings for iKang Healthcare Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iKang Healthcare Group and related companies with MarketBeat.com's FREE daily email newsletter.